European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patientsEri Yamamoto, Yoshiaki Ishigatsubo, Shin Fujisawa et al.|Cancer Science|2013Cited by 39
Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapyKazuho Miyashita, Yoshiaki Ishigatsubo, Ayumi Numata et al.|Leukemia Research|2015Cited by 35
Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective StudyTakayoshi Tachibana, Hideaki Nakajima, Taiki Andou et al.|Clinical Lymphoma Myeloma & Leukemia|2018Cited by 28
Two surgical cases of thymic MALT lymphoma associated with multiple lung cysts: possible association with Sjögren’s syndromeHiromasa Arai, Munetaka Masuda, Michihiko Tajiri et al.|General Thoracic and Cardiovascular Surgery|2016Cited by 15
A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese CohortChikako Ohwada, Shinichiro Okamoto, Emiko Sakaida et al.|Transplantation and Cellular Therapy|2019Cited by 13